Aria CV
St. Paul, US · Founded 2010 · Delaware corporation · 6 known investors
Founders & leadership
JW
Joshua WoolleyinExecutive
RG
Ryan GladneyExecutive
GG
Gary GrahamExecutive
DW
Dan W. GladneyinExecutive
PD
Peter DeLangeinExecutive
BA
Bruce A. MachmeierExecutive
KV
Karl VollmersNamed on SEC filing
JS
John ScandurraNamed on SEC filing
JG
John GainorNamed on SEC filing
Board
DZ
RM
Renee MasiBoard director
GF
George FazioBoard director
Investors · 6
Reported raises · per SEC filings
Form D private placements$13.9M disclosed across 5 of 6 rounds · 2014–2025
▶$1.4MraisedAug 2025 · 39 investors · Other Health CareRule 506(b)
▶$1.4MraisedAug 2025 · 39 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott WardDirector
- Steven YakubovDirector
- Dan W. GladneyExecutive Officer, Director
- George FazioDirector
- Darshana ZaveriDirector
- Renee MasiDirector
- Karl VollmersExecutive Officer
- John ScandurraExecutive Officer
- Peter DeLangeExecutive Officer
- Offering amount
- $6M
- Amount sold
- $1.4M
- Sales commissions
- $136.6K
- Proceeds to insiders
- $1M
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedSep 2024 · 33 investors · Other Health CareRule 506(b)
▶$2.2MraisedSep 2024 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Karl VollmersExecutive Officer
- John ScandurraExecutive Officer
- Joshua WoolleyExecutive Officer
- Ryan GladneyExecutive Officer
- Darshana ZaveriDirector
- Steven Yakubov, MDDirector
- Renee MasiDirector
- Maria Berkman, MDDirector
- George FazioDirector
- Gary GrahamExecutive Officer
- Dan W. GladneyExecutive Officer, Director
- Peter DeLangeExecutive Officer
- Jason RushtonDirector
- Offering amount
- $20M
- Amount sold
- $2.2M
- Sales commissions
- $266.3K
- Proceeds to insiders
- $1.9M
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.8MraisedJul 2022 · 23 investors · Other Health CareRule 506(b)
▶$7.8MraisedJul 2022 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Spencer KuboExecutive Officer
- Renee MasiDirector
- George FazioDirector
- John ScandurraExecutive Officer
- Peter DeLangeExecutive Officer
- Jason RushtonDirector
- Darshana ZaveriDirector
- Maria BeckmanDirector
- Dan W. GladneyExecutive Officer, Director
- Gary GrahamExecutive Officer
- Offering amount
- $13M
- Amount sold
- $7.8M
- Sales commissions
- $139.8K
- Proceeds to insiders
- $1.9M
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$666.6KraisedJan 2020 · 10 investors · Other Health CareRule 506(b)
▶$666.6KraisedJan 2020 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Renee MasiDirector
- John ScandurraExecutive Officer
- Richard SchroederExecutive Officer
- Darshana ZaveriDirector
- Maria BeckmanDirector
- Marc KnutsonExecutive Officer
- Dan W. GladneyExecutive Officer, Director
- Karl VollmersExecutive Officer
- Offering amount
- $18M
- Amount sold
- $666.6K
- Sales commissions
- $300K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedMar 2018 · 8 investors · BiotechnologyRule 506(b)
▶$1.9MraisedMar 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Renee MasiDirector
- Darshana ZaveriDirector
- John ScandurraExecutive Officer, Director
- Dan W. GladneyDirector
- Karl VollmersExecutive Officer
- John GainorExecutive Officer
- Offering amount
- $5M
- Amount sold
- $1.9M
- Minimum investment
- $100K
- Sales commissions
- $75K
- Proceeds to insiders
- $60K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.3MofferedDec 2014 · BiotechnologyRule 506(b)
▶$6.3MofferedDec 2014 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce A. MachmeierExecutive Officer
- Robert F. WilsonDirector
- John ScandurraExecutive Officer, Director
- Norman DannDirector
- Dan W. GladneyDirector
- Karl VollmersExecutive Officer
- Offering amount
- $6.3M
- Minimum investment
- $75K
- Sales commissions
- $127.5K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapOsfhealthcare4 shared keywordsOSF HealthCare is an integrated health system operating 16 hospitals, urgent care clinics, primary and specialty care facilities, and digital health services across Illinois and Michigan. The organization serves patients through inpatient care, outpatient clinics, home health services, and virtual care platforms.
Rf Surgical4 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies competing with Aria CV for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who are Aria CV's investors?
- Aria CV's investors include Angel Physicians Fund, Brightstone Venture Capital, Broadview Ventures, Portfolia, Catalyst Health Ventures, Xeraya Capital.
- How much funding has Aria CV raised?
- Aria CV has disclosed $13.9M raised across 5 of its 6 known rounds.
- Where is Aria CV headquartered?
- Aria CV is headquartered in St. Paul, US.